logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christopher Recknor

Oregon National Primate Research Center
H指数:19
被引数:2,203

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab

CCR5受体占有率分析显示用Anti-CCR5抗体Leronlimab治疗后外周血CCR5 CD4 T细胞增加

FRONTIERS IN IMMUNOLOGY
IF5.9
2021-11-1916
OAAI
Chang, Xiao L.; Wu, Helen L.; Webb, Gabriela M.; Tiwary, Meenakshi; Hughes, Colette; Reed, Jason S.; Hwang, Joseph; Waytashek, Courtney; Boyle, Carla; Pessoa, Cleiton; Sylwester, Andrew W.; Morrow, David; Belica, Karina; Fischer, Miranda; Kelly, Scott; Pourhassan, Nader; Bochart, Rachele M.; Smedley, Jeremy; Recknor, Christopher P.; Hansen, Scott G.; Sacha, Jonah B.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

相对于阿仑膦酸盐，Romosozumab可改善绝经后妇女的腰椎骨量和骨强度参数: 绝经后高危骨质疏松症妇女主动控制骨折研究 (ARCH) 的结果

JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2021-11-0148
OAAI
Brown, Jacques P.; Engelke, Klaus; Keaveny, Tony M.; Chines, Arkadi; Chapurlat, Roland; Foldes, A. Joseph; Nogues, Xavier; Civitelli, Roberto; De Villiers, Tobias; Massari, Fabio; Zerbini, Cristiano A. F.; Wang, Zhenxun; Oates, Mary K.; Recknor, Christopher; Libanati, Cesar
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study

基于重塑和建模的骨形成与特瑞帕肽与地诺塞麦的比较: 在AVA研究中从基线到3个月的纵向分析

JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2017-10-1255
OAAI
Dempster, David W.; Zhou, Hua; Recker, Robert R.; Brown, Jacques P.; Recknor, Christopher P.; Lewiecki, E. Michael; Miller, Paul D.; Rao, Sudhaker D.; Kendler, David L.; Lindsay, Robert; Krege, John H.; Alam, Jahangir; Taylor, Kathleen A.; Melby, Thomas E.; Ruff, Valerie A.
A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial
JOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
2016-02-0336
OAAI
Dempster, David W.; Zhou, Hua; Recker, Robert R.; Brown, Jacques P.; Bolognese, Michael A.; Recknor, Christopher P.; Kendler, David L.; Lewiecki, E. Michael; Hanley, David A.; Rao, Sudhaker D.; Miller, Paul D.; Woodson, Grattan C., III; Lindsay, Robert; Binkley, Neil; Alam, Jahangir; Ruff, Valerie A.; Gallagher, Eileen R.; Taylor, Kathleen A.
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate

与每月口服伊班膦酸盐和利塞膦酸盐相比，Denosumab显着增加了绝经后妇女的骨矿物质密度并减少了骨转换，尽管以前使用口服双膦酸盐进行了次优治疗，但仍有较高的骨折风险

OSTEOPOROSIS INTERNATIONAL
IF5.4
2014-03-2843
PREAI
Brown, J. P.; Roux, C.; Ho, P. R.; Bolognese, M. A.; Hall, J.; Bone, H. G.; Bonnick, S.; van den Bergh, J. P.; Ferreira, I.; Dakin, P.; Wagman, R. B.; Recknor, C.
Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial

接受特瑞帕肽或唑来膦酸治疗 (SHOTZ) 研究的受试者的骨骼组织形态计量学: 一项随机对照试验

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
2012-08-0173
OAAI
Dempster, David W.; Zhou, Hua; Recker, Robert R.; Brown, Jacques P.; Bolognese, Michael A.; Recknor, Christopher P.; Kendler, David L.; Lewiecki, E. Michael; Hanley, David A.; Rao, D. Sudhaker; Miller, Paul D.; Woodson, Grattan C., III; Lindsay, Robert; Binkley, Neil; Wan, Xiaohai; Ruff, Valerie A.; Janos, Boris; Taylor, Kathleen A.

研究方向

暂未获取到该数据
J
Jacques P. Brown
H 指数:87论文数:477被引数:3.5万
D
David L. Kendler
H 指数:68论文数:252被引数:2.1万
R
Robert R. Recker
H 指数:108论文数:634被引数:5.3万
E
E. Michael Lewiecki
H 指数:79论文数:450被引数:3.2万
J
Jahangir Alam
H 指数:24论文数:172被引数:2,333
J
John H. Krege
H 指数:53论文数:137被引数:1.2万
F
Felicia Cosman
H 指数:79论文数:308被引数:3.0万
D
David W. Dempster
H 指数:82论文数:299被引数:2.9万
M
Michael A. Bolognese
H 指数:45论文数:106被引数:1.2万
H
Hua Zhou
H 指数:55论文数:339被引数:1.0万